6-Chloro-7-deazapurine-2F-β-D-arabinofuranose
6-Chloro-7-deazapurine-2F-β-D-arabinofuranose is a nucleoside derivative. 6-Chloro-7-deazapurine-2F-β-D-arabinofuranose can be used for synthesis of antiviral agent against hepatitis C virus infection[1].
Product Specifications
CAS Number
169516-60-3
UNSPSC
12352005
Target
HCV; Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/6-chloro-7-deazapurine-2f-β-d-arabinofuranose.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1[C@@H](O)[C@H](F)[C@H](N2C3=NC=NC(Cl)=C3C=C2)O1
Molecular Formula
C11H11ClFN3O3
Molecular Weight
287.67
References & Citations
[1]Vincenzo Summa, et al. Antiviral agents for the treatment of hepatitis C virus infections. Patent. WO2010084115.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940031-100 1x 100 µL
Mucin 5AC (MUC5AC) (45M1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC140017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740723-100 1x 100 µL
P53 (BP53-12 + DO-7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details